On Tuesday, shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) experienced volatile short activity. After the activity, the stock price went up +5.67% to $9.88.
The overall sentiment for FOLD has been Bearish.
Key takeaways:
Weibo’s revenue rose above pre-pandemic levels last year, but its profitability lagged due to heavy spending
The company trails Meta in its ability to monetize users, and is very much in the shadow of local rival WeChat in terms of total user numbers
By Ken Lo